Total Company Value: allovir.com (ALVR)

The price trajectory for AlloVir, Inc. (ALVR) shown below on the GURU.Markets platform, where the Enterprise Value is , confirms the asset's status as a defensive instrument independent of global economic fluctuations. The business focuses on developing cellular antiviral therapies for transplant patients. Simultaneously, AlloVir, Inc. (ALVR) is implementing eco-friendly chemical disposal standards and energy-efficient storage for biological samples.

ALVR (AlloVir Inc) Total Company Value history from 07/04/2022 to 10/28/2026

AlloVir (ALVR) - metric breakdowns and financial figures

- price and consensus price forecast:

Price Chart AlloVir Inc|ALVR - Consensus Target

- market capitalization data:

Market Value AlloVir|ALVR - Total Company Value

- book capitalization data:

Accounting Value of a Share AlloVir|ALVR - Company Book Value|Market Capitalization to Net Assets allovir.com|ALVR - Company Total Assets

- debt and liquidity data:

Comprehensive company analysis:AlloVir, Inc. (ALVR)

Enterprise Value (EV) represents the total buyout price of a business, combining market capitalization with net debt to determine the objective value of assets. The price action of the actual business buyout reflects the impact of cash reserves amid the freeze of clinical trials at AlloVir, Inc. (ALVR), allowing for an assessment of the company's financial stability during a deep revision of its R&D pipeline.

Competitor analysis for AlloVir, Inc.

GILD - Total Company Value|CDTX - Real Price to Acquire Entire Company|NVAX: Total Company Value|Total Company Value CureVac N.V. CVAC|VALN (valneva.com) - Value Adjusted for Debt and Cash|Total Company Value Vir Biotechnology VIR|Full Business Value SIGA Technologies Inc|Emergent Corp (EBS) - Enterprise Value|Value Adjusted for Debt and Cash Atea Corp (AVIR)|Enterprise Value IVVD (Invivyd)|enanta.com - Enterprise Value|Total Company Value Inovio (INO)|HLVX: Value Adjusted for Debt and Cash|KLRS (Kalaris Therapeutics, Inc.) - Total Company Value|Dyadic International, Inc. (DYAI) - Real Price to Acquire Entire Company|NNVC (NanoViricides Inc.) - Enterprise Value|Enterprise Value talphera.com (TLPH)|Cocrystal Pharma (COCP) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash trawspharma.com TRAW|Real Price to Acquire Entire Company Dogwood Therapeutics DWTX|Total Company Value Qualigen Corp QLGN|Enterprise Value VBIV (VBI Vaccines Inc)|VIRI: Company Buyout Price|Total Company Value vaxart.com VXRT